Cargando…

Associations Between Oral Health Status, Perceived Stress, and Neuropsychiatric Symptoms Among Community Individuals With Alzheimer's Disease: A Mediation Analysis

Community individuals with Alzheimer's disease (AD) experience oral disease alongside neuropsychiatric symptoms (NPS) with disease progression. Despite growing evidence for the link between oral health and cognitive status, few studies have investigated the associations between oral health and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bing, Tao, Binbin, Yin, Qianyu, Chai, Zhaowu, Xu, Ling, Zhao, Qinghua, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786079/ https://www.ncbi.nlm.nih.gov/pubmed/35082659 http://dx.doi.org/10.3389/fnagi.2021.801209

Ejemplares similares

Neuropsychiatric Symptoms Mediated the Relationship Between Odor Identification and Cognition in Alzheimer's Disease Spectrum: A Structural Equation Model Analysis
por: Wang, Qiang, et al.
Publicado: (2022)

Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer’s Disease: An Update of a Systematic Review and Meta-Analysis
por: Liang, Ya-Jing, et al.
Publicado: (2022)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Health-Related Predictors of Changes in Cognitive Status in Community-Dwelling Older Individuals
por: Trevisan, Caterina, et al.
Publicado: (2022)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
por: Keszycki, Rachel, et al.
Publicado: (2023)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

The Correlation Between Falls and Cognitive Frailty in Elderly Individuals With Hypertension in a Chinese Community
por: Wang, Can, et al.
Publicado: (2022)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
por: Frausto, Dulce M., et al.
Publicado: (2022)

Highlighting the value of Alzheimer’s disease-focused registries: lessons learned from cancer surveillance
por: Miller, Margaret C., et al.
Publicado: (2023)

Effects of DISC1 on Alzheimer’s disease cell models assessed by iTRAQ proteomics analysis
por: Lu, Jiajie, et al.
Publicado: (2022)

Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes
por: Wang, Hoau-Yan, et al.
Publicado: (2023)

Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
por: Prud’homme, Gérald J., et al.
Publicado: (2022)

Perceived stress and depressive symptoms not neuropsychiatric symptoms predict caregiver burden in Alzheimer’s disease: a cross-sectional study
por: Pinyopornpanish, Manee, et al.
Publicado: (2021)

Exploratory studies of oral and fecal microbiome in healthy human aging
por: Zhou, Xin, et al.
Publicado: (2022)

Development of a system to analyze oral frailty associated with Alzheimer's disease using a mouse model
por: Kuramoto, Eriko, et al.
Publicado: (2022)

The Neuropsychiatric Changes After COVID-19 Quarantine in Patients With Cognitive Impairment and Their Caregivers in Chongqing, China: A Cohort Study
por: Yuan, Shiyun, et al.
Publicado: (2022)

Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging
por: Peng, Shouneng, et al.
Publicado: (2021)

Comparison of Methods for Algorithmic Classification of Dementia Status in the Health and Retirement Study
por: Gianattasio, Kan Z., et al.
Publicado: (2019)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
por: Iravani, Behnam, et al.
Publicado: (2022)

Network Analysis of Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19
por: Bueno, Valquiria, et al.
Publicado: (2023)

Ginseng intake and Alzheimer disease-specific cognition in older adults according to apolipoprotein ε4 allele status
por: Lee, Boung Chul, et al.
Publicado: (2023)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus
por: Frasca, Daniela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56rna6tql3jsitj1uodmskl39p